Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ABCL – AbCellera Biologics Inc.

Name : AbCellera Biologics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
finviz dynamic chart for ABCL
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ABCL &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

10.05

Margin Of Safety %

Put/Call OI Ratio

0.19

EPS Next Q Diff

-0.01

EPS Last/This Y

-0.09

EPS This/Next Y

0.01

Price

2.37

Target Price

8.43

Analyst Recom

1.22

Performance Q

-0.42

Relative Volume

1

Beta

0.36

Ticker: ABCL




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-05-07ABCL2.020.260.0216824
2025-05-08ABCL2.010.250.0617393
2025-05-09ABCL2.030.240.1117791
2025-05-12ABCL2.060.230.0318420
2025-05-13ABCL2.110.220.6718093
2025-05-14ABCL2.060.270.0118944
2025-05-15ABCL2.020.261.9919319
2025-05-16ABCL2.030.260.8619365
2025-05-19ABCL2.030.280.0417457
2025-05-20ABCL2.090.270.0017906
2025-05-21ABCL1.990.270.8318183
2025-05-22ABCL1.990.250.0117904
2025-05-23ABCL1.9750.240.3918293
2025-05-27ABCL1.980.240.3318280
2025-05-28ABCL2.030.230.0018657
2025-05-29ABCL2.0450.230.1318756
2025-05-30ABCL2.030.220.0018855
2025-06-02ABCL2.140.220.0418853
2025-06-03ABCL2.310.220.0719310
2025-06-04ABCL2.420.200.1421145
2025-06-05ABCL2.360.190.0922776
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-05-07ABCL2.01-1.8- -0.66
2025-05-08ABCL2.01-1.8- -0.66
2025-05-09ABCL2.03-1.8- -0.66
2025-05-12ABCL2.06-1.8- -0.66
2025-05-13ABCL2.10-1.8- -0.66
2025-05-14ABCL2.06-26.9- -0.67
2025-05-15ABCL2.02-26.9- -0.67
2025-05-16ABCL2.04-24.6- -0.66
2025-05-19ABCL2.02-21.8- -0.65
2025-05-20ABCL2.10-21.8- -0.65
2025-05-21ABCL1.99-21.8- -0.65
2025-05-22ABCL2.00-21.8- -0.65
2025-05-23ABCL1.98-21.8- -0.65
2025-05-27ABCL1.98-21.8- -0.65
2025-05-28ABCL2.04-21.8- -0.65
2025-05-29ABCL2.04-21.8- -0.65
2025-05-30ABCL2.02-21.8- -0.65
2025-06-02ABCL2.14-21.8- -0.65
2025-06-03ABCL2.31-21.8- -0.65
2025-06-04ABCL2.42-21.8- -0.65
2025-06-05ABCL2.37-21.8- -0.65
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-05-07ABCL0.0011.6810.64
2025-05-08ABCL0.0011.6810.64
2025-05-09ABCL0.0011.6810.62
2025-05-12ABCL0.0010.9910.27
2025-05-13ABCL0.0010.9910.27
2025-05-14ABCL0.0010.9910.27
2025-05-15ABCL0.0010.9910.27
2025-05-16ABCL0.0010.9910.27
2025-05-19ABCL0.007.4410.27
2025-05-20ABCL0.007.4410.27
2025-05-21ABCL0.007.4410.27
2025-05-22ABCL0.007.4410.27
2025-05-23ABCL0.007.4410.27
2025-05-27ABCL0.0013.0310.27
2025-05-28ABCL0.0013.0310.05
2025-05-29ABCL0.0013.0310.05
2025-05-30ABCL0.0013.0310.05
2025-06-02ABCL0.0012.7410.05
2025-06-03ABCL0.0012.7410.05
2025-06-04ABCL0.0012.7410.05
2025-06-05ABCL0.0012.7410.05
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL 589 360 ]

Last Quarter Act. EPS

-0.15

Avg. EPS Est. Current Quarter

-0.16

Avg. EPS Est. Next Quarter

-0.16

Insider Transactions

Institutional Transactions

12.74

Beta

0.36

Average Sales Estimate Current Quarter

7

Average Sales Estimate Next Quarter

7

Fair Value

Quality Score

24

Growth Score

34

Sentiment Score

45

Actual DrawDown %

96.7

Max Drawdown 5-Year %

Target Price

8.43

P/E

Forward P/E

PEG

P/S

30.6

P/B

0.69

P/Free Cash Flow

EPS

-0.57

Average EPS Est. Cur. Y​

-0.65

EPS Next Y. (Est.)

-0.63

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-726.23

Relative Volume

1

Return on Equity vs Sector %

-40.4

Return on Equity vs Industry %

-22.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL 589 450 ]
AbCellera Biologics Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 596
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today
news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance
stock history ABCL – AbCellera Biologics Inc. invest stock market
stock prices ABCL premarket after hours
ticker ABCL fair value insiders trading